Robles BioCeutics Signs Manufacturing Partnership Agreement with Innovigen to Accelerate Production of Regenerative Skincare Line
Regenerative Dermatology Company Advances Scalable Production of Senolytic-Enhanced Stem Cell Formulations Through Strategic Manufacturing Agreement
SAN DIEGO, July 28, 2025 /PRNewswire/ -- Robles BioCeutics, a science-driven regenerative dermatology company developing skin-permeable senolytics and stem cell-powered cosmetics, announced today its strategic manufacturing partnership with Innovigen, a California-based formulation and production company specializing in cellular and cosmetic GMP production.
The agreement marks a major milestone in Robles BioCeutics' journey to bring its first product, GlowSelle™, to market. The collaboration will focus on refining, scaling, and manufacturing GlowSelle™ and future product lines, leveraging Innovigen's expertise in advanced formulation, quality control, and regulatory compliance.
"We've been very intentional about selecting a partner who shares our commitment to innovation, transparency, and results-driven formulation," said Maria Robles, CEO and Founder of Robles BioCeutics. "Innovigen brings not only technical excellence, but also the flexibility and vision needed to help us deliver a product that reflects the future of anti-aging skincare."
Under the terms of agreement, Innovigen will support joint refinement and scale-up of cosmetic formulations, including potential guidance on ingredient sourcing. The partnership includes contract manufacturing services for GlowSelle™ and future Robles BioCeutics product lines, covering batch production, packaging, quality assurance, and defined release criteria. In addition, the companies will explore co-development opportunities for next-generation skincare products rooted in regenerative science and biotechnology. Both parties have agreed to maintain strict confidentiality and protect proprietary information throughout this collaboration and in any future engagement.
GlowSelle™, the company's flagship product, is rooted in senolytic and stem cell science— designed to stimulate the skin's natural regenerative processes by leveraging growth factors produced under injury-mimicking conditions.
"We are highly impressed by the work of Robles BioCeutics which has been featured in numerous peer-reviewed settings, most recently being highlighted by a presentation at the prestigious American Association of Immunologists™ meeting1. This partnership is a natural fit," said Michael Wang, Founder and CEO of Innovigen. "Robles BioCeutics is pushing the boundaries of what's possible in topical skincare using regenerative sciences, and we're proud to help bring that vision to life."
About Robles BioCeutics
Robles BioCeutics is a regenerative dermatology company focused on delivering high-performance skincare powered by science. Combining the latest advances in senolytics and stem cell-derived technologies, the company aims to redefine aging from the surface in.
About Innovigen
Innovigen is a Californian-based cosmetic manufacturing company specializing in the formulation and production of skincare, wellness, and personal care products. Known for its commitment to quality, innovation, and collaboration, Innovigen partners with brands to bring cutting-edge products to life.
For updates, follow Robles BioCeutics on Instagram, Twitter, Facebook, and Youtube, or visit us at www.roblesbioceutics.com
For more information, please contact: Maria Robles
CEO and President
Robles BioCeutics
398697@email4pr.com
858-609-0948
View original content to download multimedia:https://www.prnewswire.com/news-releases/robles-bioceutics-signs-manufacturing-partnership-agreement-with-innovigen-to-accelerate-production-of-regenerative-skincare-line-302514901.html
SOURCE Robles BioCeutics